Chinese Ministry of Commerce approves Nestle's US$11.85B bid to buy Pfizer's infant nutrition business; Nestle still needs approvals from anti-trust bodies in several other countries
November 2, 2012
(Industry Intelligence Inc.)
– The Chinese Ministry of Commerce has approved Nestle SA's US$11.85 billion bid to buy Pfizer's infant nutrition business, Dow Jones Newswires reported Nov. 2.
Nestle still needs approvals from anti-trust bodies in several other countries.
The primary source of this article is Dow Jones Newswires, New York, New York, on Nov. 2, 2012.